Literature DB >> 10328965

Altered corneal stromal matrix organization is associated with mucopolysaccharidosis I, III and VI.

J Alroy1, M Haskins, D E Birk.   

Abstract

The presence of cloudy corneas is a prominent feature of mucopolysaccharidosis (MPS) types I and VI, but not MPS IIIA or IIIB. The cause of corneal cloudiness in MPS I and VI is speculative. Transparency of the cornea is dependent on the uniform diameter and the regular spacing and arrangement of the collagen fibrils within the stroma. Alterations in the spacing of collagen fibrils in a variety of conditions including corneal edema, scars, and macular corneal dystrophy is clinically manifested as corneal opacity. The purpose of this study was to compare the structural organization of the stromal extracellular matrix of normal corneas with that of MPS corneas. The size and arrangement of collagen fibrils in cloudy corneas from patients with MPS I were examined. The alterations observed were an increased mean fibril diameter with a broader distribution in the MPS corneas. The MPS I corneas also had altered fibril spacing and more irregular packing compared with normal control corneas. The clear corneas of patients with MPS IIIA and IIIB also showed increases in mean fibril diameter and fibril spacing. However, there was less variation indicating more regularity than seen in MPS I. In addition, corneas from cat models of certain MPS were compared to the human corneas. Cats with MPS I and VI, as well as normal control cats, were examined. Structural alterations comparable to those seen in human MPS corneas were seen in MPS I and VI cats relative to normal clear corneas. The findings suggest that cloudy corneas in MPS I and VI are in part a consequence of structural alterations in the corneal stroma, including abnormal spacing, size, and arrangement of collagen fibrils. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10328965     DOI: 10.1006/exer.1998.0622

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  18 in total

1.  Liver-directed gene therapy corrects cardiovascular lesions in feline mucopolysaccharidosis type I.

Authors:  Christian Hinderer; Peter Bell; Brittney L Gurda; Qiang Wang; Jean-Pierre Louboutin; Yanqing Zhu; Jessica Bagel; Patricia O'Donnell; Tracey Sikora; Therese Ruane; Ping Wang; Mark E Haskins; James M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

2.  Corrective GUSB transfer to the canine mucopolysaccharidosis VII cornea using a helper-dependent canine adenovirus vector.

Authors:  Nicolas Serratrice; Aurelie Cubizolle; Sandy Ibanes; Nadine Mestre-Francés; Neus Bayo-Puxan; Sophie Creyssels; Aurelie Gennetier; Florence Bernex; Jean-Michel Verdier; Mark E Haskins; Guilhem Couderc; Francois Malecaze; Vasiliki Kalatzis; Eric J Kremer
Journal:  J Control Release       Date:  2014-03-04       Impact factor: 9.776

Review 3.  Hurdles in treating Hurler disease: potential routes to achieve a "real" cure.

Authors:  Brigitte T A van den Broek; Jaap van Doorn; Charlotte V Hegeman; Stefan Nierkens; Caroline A Lindemans; Nanda Verhoeven-Duif; Jaap Jan Boelens; Peter M van Hasselt
Journal:  Blood Adv       Date:  2020-06-23

4.  Pathogenesis of mitral valve disease in mucopolysaccharidosis VII dogs.

Authors:  Paul W Bigg; Guilherme Baldo; Meg M Sleeper; Patricia A O'Donnell; Hanqing Bai; Venkata R P Rokkam; Yuli Liu; Susan Wu; Roberto Giugliani; Margret L Casal; Mark E Haskins; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2013-06-25       Impact factor: 4.797

5.  Corneal opacity in lumican-null mice: defects in collagen fibril structure and packing in the posterior stroma.

Authors:  S Chakravarti; W M Petroll; J R Hassell; J V Jester; J H Lass; J Paul; D E Birk
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-10       Impact factor: 4.799

Review 6.  Corneal stroma microfibrils.

Authors:  Samuel D Hanlon; Ali R Behzad; Lynn Y Sakai; Alan R Burns
Journal:  Exp Eye Res       Date:  2015-01-19       Impact factor: 3.467

7.  Bone marrow transplantation for feline mucopolysaccharidosis I.

Authors:  N Matthew Ellinwood; Marie-Anne Colle; Margaret A Weil; Margret L Casal; Charles H Vite; Staci Wiemelt; Christopher W Hasson; Thomas M O'Malley; Xingxuan He; Ulana Prociuk; Lucie Verot; John R Melniczek; Anne Lannon; Gustavo D Aguirre; Van W Knox; Sydney M Evans; Marie T Vanier; Edward H Schuchman; Steven U Walkley; Mark E Haskins
Journal:  Mol Genet Metab       Date:  2007-05-07       Impact factor: 4.797

8.  Regulation by P2X7: epithelial migration and stromal organization in the cornea.

Authors:  Courtney Mayo; Ruiyi Ren; Celeste Rich; Mary Ann Stepp; Vickery Trinkaus-Randall
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-23       Impact factor: 4.799

9.  Intrastromal Gene Therapy Prevents and Reverses Advanced Corneal Clouding in a Canine Model of Mucopolysaccharidosis I.

Authors:  Keiko Miyadera; Laura Conatser; Telmo A Llanga; Kendall Carlin; Patricia O'Donnell; Jessica Bagel; Liujiang Song; Joanne Kurtzberg; R Jude Samulski; Brian Gilger; Matthew L Hirsch
Journal:  Mol Ther       Date:  2020-04-11       Impact factor: 11.454

Review 10.  Ocular manifestations and management recommendations of lysosomal storage disorders I: mucopolysaccharidoses.

Authors:  Carlton R Fenzl; Kyla Teramoto; Majid Moshirfar
Journal:  Clin Ophthalmol       Date:  2015-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.